386 related articles for article (PubMed ID: 10340378)
1. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
2. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
Rajala RV; Chan MD
Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
[TBL] [Abstract][Full Text] [Related]
5. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
Chen H; Yan GC; Gishizky ML
Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
[TBL] [Abstract][Full Text] [Related]
6. A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and Shc in HEK 293 cells.
Strack V; Bossenmaier B; Stoyanov B; Mushack J; Häring HU
Diabetologia; 1997 Oct; 40(10):1135-40. PubMed ID: 9349593
[TBL] [Abstract][Full Text] [Related]
7. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.
Farooq A; Plotnikova O; Zeng L; Zhou MM
J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
9. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
10. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.
Wolf G; Trüb T; Ottinger E; Groninga L; Lynch A; White MF; Miyazaki M; Lee J; Shoelson SE
J Biol Chem; 1995 Nov; 270(46):27407-10. PubMed ID: 7499194
[TBL] [Abstract][Full Text] [Related]
11. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
12. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins.
Shpakov AO; Pertseva MN
Membr Cell Biol; 2000; 13(4):455-84. PubMed ID: 10926366
[TBL] [Abstract][Full Text] [Related]
14. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor.
Eck MJ; Dhe-Paganon S; Trüb T; Nolte RT; Shoelson SE
Cell; 1996 May; 85(5):695-705. PubMed ID: 8646778
[TBL] [Abstract][Full Text] [Related]
15. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction through the IL-4 and insulin receptor families.
Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
[TBL] [Abstract][Full Text] [Related]
17. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.
Gustafson TA; He W; Craparo A; Schaub CD; O'Neill TJ
Mol Cell Biol; 1995 May; 15(5):2500-8. PubMed ID: 7537849
[TBL] [Abstract][Full Text] [Related]
18. In vitro phosphorylation of insulin receptor substrate 1 by protein kinase C-zeta: functional analysis and identification of novel phosphorylation sites.
Sommerfeld MR; Metzger S; Stosik M; Tennagels N; Eckel J
Biochemistry; 2004 May; 43(19):5888-901. PubMed ID: 15134463
[TBL] [Abstract][Full Text] [Related]
19. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
Ahmed Z; Pillay TS
Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
[TBL] [Abstract][Full Text] [Related]
20. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
